6,8-Dichloro-9H-beta-carboline

ID: ALA78464

PubChem CID: 11075446

Max Phase: Preclinical

Molecular Formula: C11H6Cl2N2

Molecular Weight: 237.09

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Clc1cc(Cl)c2[nH]c3cnccc3c2c1

Standard InChI:  InChI=1S/C11H6Cl2N2/c12-6-3-8-7-1-2-14-5-10(7)15-11(8)9(13)4-6/h1-5,15H

Standard InChI Key:  FMHUTFHLSOWTSV-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 15 17  0  0  0  0  0  0  0  0999 V2000
    2.9417   -1.0500    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2792   -0.5667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5375    0.2208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6125   -0.5667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3542    0.2208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4792   -0.7417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9250   -0.1292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9792    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1792    0.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9667   -0.1292    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2292   -1.5250    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    4.4167   -0.7417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6292    1.2625    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.9125    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7125    0.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  2  0
  4  1  1  0
  5  4  2  0
  6  2  1  0
  7  6  2  0
  8  3  1  0
  9  7  1  0
 10 12  2  0
 11  6  1  0
 12  4  1  0
 13  9  1  0
 14  5  1  0
 15 10  1  0
  5  3  1  0
 15 14  2  0
  8  9  2  0
M  END

Alternative Forms

Associated Targets(Human)

CHUK Tchem Inhibitor of nuclear factor kappa B kinase alpha subunit (3170 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CSNK2B Tbio Casein kinase II (1406 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRKACB Tchem cAMP-dependent protein kinase (PKA) (929 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRKD3 Tchem Protein kinase C (PKC) (1010 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 237.09Molecular Weight (Monoisotopic): 235.9908AlogP: 4.02#Rotatable Bonds:
Polar Surface Area: 28.68Molecular Species: NEUTRALHBA: 1HBD: 1
#RO5 Violations: HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 12.06CX Basic pKa: 5.44CX LogP: 3.08CX LogD: 3.08
Aromatic Rings: 3Heavy Atoms: 15QED Weighted: 0.63Np Likeness Score: -0.64

References

1. Castro AC, Dang LC, Soucy F, Grenier L, Mazdiyasni H, Hottelet M, Parent L, Pien C, Palombella V, Adams J..  (2003)  Novel IKK inhibitors: beta-carbolines.,  13  (14): [PMID:12824047] [10.1016/s0960-894x(03)00408-6]
2. Ikeda R, Kimura T, Tsutsumi T, Tamura S, Sakai N, Konakahara T..  (2012)  Structure-activity relationship in the antitumor activity of 6-, 8- or 6,8-substituted 3-benzylamino-β-carboline derivatives.,  22  (10): [PMID:22520257] [10.1016/j.bmcl.2012.03.077]

Source